South Korea · Healthcare · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
10.03%
2025 (actual)
ROA
9.47%
2025 (actual)
Gross Margin
67.13%
2025 (actual)
Net Margin
34.76%
2025 (actual)
Total Assets
₩73,449.6M
2025 (actual)
Net Income
₩6,666.2M
2025 (actual)
Valuation
₩134,757.39M
2026 (forecast)
Stock Price
₩15,800
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-1.8 pt
Company
ROA
-1.7 pt
Company
Gross Margin
-8.1 pt
Company
Sector average
Net Margin
-9.7 pt
Company
Total Assets
+62.7%
Company
Sector average (own scale)
Net Income
+34.6%
Company
Valuation
+32.2%
Company
Sector average (own scale)
Stock Price
+32.2%
Company
Sector average
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for BIO-FD&C Co.,Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.